Avanir Pharmaceuticals to Participate in Two Conferences in May

ALISO VIEJO, Calif., May 1, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that company management will present an overview of the company at the following conferences in May.

  • Deutsche Bank 39th Annual Health Care Conference
    • Presentation date: Thursday, May 8, 2014
    • Presentation time: 2:10 p.m. E.T.

  • Bank of America Merrill Lynch 2014 Health Care Conference
    • Presentation date: Tuesday, May 13, 2014
    • Presentation time: 1:00 p.m. P.T.
Avanir Pharmaceuticals, Inc.

A live webcast and 30-day archive of these presentations will be available at http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
+1 (949) 389-6700

Logo - http://photos.prnewswire.com/prnh/20130207/LA55901LOGO

SOURCE Avanir Pharmaceuticals, Inc.